Your browser doesn't support javascript.
loading
Feasibility and Tolerability of Adjuvant Capecitabine-Based Chemoradiation in Patients With Breast Cancer and Residual Disease After Neoadjuvant Chemotherapy: A Prospective Clinical Trial.
Balbach, Meridith L; Sherry, Alexander D; Rexer, Brent N; Abramson, Vandana G; Niermann, Kenneth J; Johnson, Corbin R; Park, Ben Ho; Mayer, Ingrid A; Chakravarthy, A Bapsi.
Affiliation
  • Balbach ML; Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Sherry AD; Department of Radiation Oncology, Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Rexer BN; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Abramson VG; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Niermann KJ; Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Johnson CR; Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Park BH; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Mayer IA; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Chakravarthy AB; Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, Tennessee. Electronic address: bapsi.chak@vumc.org.
Int J Radiat Oncol Biol Phys ; 118(5): 1262-1270, 2024 Apr 01.
Article in En | MEDLINE | ID: mdl-37433376

Full text: 1 Database: MEDLINE Main subject: Rectal Neoplasms / Breast Neoplasms / Dermatitis Type of study: Clinical_trials / Risk_factors_studies Limits: Female / Humans Language: En Journal: Int J Radiat Oncol Biol Phys Year: 2024 Type: Article

Full text: 1 Database: MEDLINE Main subject: Rectal Neoplasms / Breast Neoplasms / Dermatitis Type of study: Clinical_trials / Risk_factors_studies Limits: Female / Humans Language: En Journal: Int J Radiat Oncol Biol Phys Year: 2024 Type: Article